维普中文期刊产品整合服务
16篇 您的检索式:作者名="Stolk LM"
    题名 作者 年代 出处 被引量
1Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms 显示文摘Op den Buijsch RA Christiaans MH Stolk LM 2007Fundam Clin Pharmacol2007,21,4:1
2Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimusformulation in kidney transplantation显示文摘Stifft F Stolk LM Undre N 2014Transplantation2014,97,7:1
3Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study显示文摘HART LM STOLK RP HEINE RJ 1996AM J Hum Genel1996,59,5:1
4Tacrolimus pharmacokinetics and pharmacogenetics: in- fluence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms 显示文摘Op den Buijsch RA Christiaans MH Stolk LM 2007Fundam Clin Pharmacol2007,21,4:1
5Evaluation of limited sampling strategies for tacrolimus 显示文摘Buijsch RA Plas A Stolk LM 2007Eur J Clin Pharmacol2007,63,11:1
6Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls 显示文摘Edelbroek PM van der Heijden J Stolk LM 2009Ther Drug Monit2009,31,3:1
7Dissolution profiles of mesalazine formulations in vitro显示文摘Stolk LM Rietbroek R Wiltink EH 1990Pharm Weekbl Sci1990,12,5:1
8Rifampicin cross-reacts with opiate immunoassay显示文摘Van As H Stolk LM 1999J Anal Toxicol1999,23,1:1
9Tacrolimus pharmacokinetics and pharmacoge- netics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms显示文摘Op den Buijsch RA Christiaans MH Stolk LM 2007Fundam Clin Pharmacol2007,21,4:1
10Lower variability in 24- hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation 显示文摘Stifft F Stolk LM Undre N 2014Transplantation2014,97,7:1
11Vancomycin therapeutic guidelines: closer examination of neonatal pharmacokinetics显示文摘Croes S Stolk LM 2011Clin Infect Dis2011,53,9:1
12Prevalence of variants in candidate gene for type 2diabetes mellitus in the Netherlands:the Rotterdam study and the Hoom study 显示文摘Hart LM Stolk RP Dekker JM 1999J Clin Endocr Metab1999,84,3:1
13Biopharmaceutics,pharmacokinetics and pharmacology of psoralens显示文摘Stolk LM Siddiqui AH 1988Gen Pharmacol1988,19,5:1
14Lower variability in24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation 显示文摘Stifft F Stolk LM Undre N 2014Transplantation2014,97,7:1
15Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands:the Rotterdam study and the Hoorn study显示文摘Hart LM Stolk RP Dekker JM 1999J Clin Endocrinol Metab1999,84,3:1
16L-phenylalanine and UVA irradiation in the treatment of vitiligo 显示文摘Siddiqul AH Stolk LM Bhaggoe R 1994Dermatology1994,188,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费